Revolution Medicines to Participate in November 2026 Investor Conferences
Globe Newswire•27/10/2026•16:05 ET
0
Key Highlights
- ➤Revolution Medicines CEO Mark A. Goldsmith to participate in two November investor conferences
- ➤Guggenheim Healthcare Innovation Conference fireside chat scheduled for November 10 at 8:30 a.m. ET
- ➤Jefferies Global Healthcare Conference fireside chat scheduled for November 16 at 5:30 a.m. ET
REDWOOD CITY, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will participate in two upcoming investor conferences.
Details of the company’s participation are as follows: * 3rd Annual Guggenheim Healthcare Innovation Conference 2026 * Fireside Chat Date/Time: Tuesday, November 10 at 8:30 a.m. ET
Get started
Create a free account to read the full story.